(Q34084153)

30 July 2017

Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

30 July 2017

0 references

1 reference

Kareem L Graham

1

1 reference

30 July 2017

Lowen Y Lee

2

1 reference

30 July 2017

John P Higgins

3

1 reference

30 July 2017

Lawrence Steinman

4

1 reference

30 July 2017

Paul J Utz

5

1 reference

30 July 2017

Peggy P Ho

6

1 reference

30 July 2017

1 July 2008

1 reference

30 July 2017

Arthritis & Rheumatology

1 reference

30 July 2017

58

1 reference

30 July 2017

7

1 reference

30 July 2017

2098-2104

1 reference

Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

Atherogenesis and autoimmune disease: the model of lupus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

Cyclophosphamide: new approaches for systemic lupus erythematosus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

Therapy with statins in patients with refractory rheumatic diseases: a preliminary study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

Safety of HMG-CoA reductase inhibitors: focus on atorvastatin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Reci

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FART.23605

Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

Atorvastatin does not decrease or delay diabetes onset in two different mouse models of type 1 diabetes

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143381

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18576356

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/ART.23605

1 reference

30 July 2017

1 reference

30 July 2017

1 reference